Pulmonary Tumor Thrombotic Microangiopathy: A Clinical Analysis of 30 Autopsy Cases
Open Access
- 1 January 2013
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 52 (12) , 1317-1323
Abstract
Objective Pulmonary tumor thrombotic microangiopathy (PTTM) is a unique, rare and fatal form of pulmonary arterial tumor embolism. The aim of this study was to evaluate the clinical characteristics and pathological and immunohistochemical findings of PTTM. Methods Autopsy records dated between January 1983 and May 2008 in our hospital were reviewed, and those of patients who died from pulmonary tumor embolism resulting from malignant neoplasm were retrieved. The relevant tissue slides were reevaluated and examined immunohistochemically to confirm the diagnosis. Results Among 2,215 consecutive autopsy cases of carcinoma, 30 patients (1.4%) were diagnosed with definitive PTTM. The common symptom was progressive dyspnea. A hypercoagulative state was observed in all measured cases (n = 21). The chest computed tomography findings (n = 6) included consolidation, ground-glass opacity, small nodules and a tree-in-bud appearance. Perfusion scans were performed in seven patients, six of whom demonstrated multiple small defects. The median survival time after the initiation of oxygen supplementation was nine days. The most frequent primary site was the stomach (n = 18 ; 60%) , and the most frequent histological type was adenocarcinoma (28/30 ; 93.3%) . The immunohistochemical findings for tumor cells located within the tumor emboli were positive for vascular endothelial growth factor (28/29 ; 96.6%) and tissue factor (29/29 ; 100%). Conclusion Clinicians should suspect PTTM in cancer patients who exhibit acute worsening respiratory insufficiency accompanied by a hypercoagulative state without embolism in major pulmonary arteries. The PTTM patients evaluated in our study had very poor prognoses. Vascular endothelial growth factor and tissue factor may play important roles in PTTM.Keywords
This publication has 13 references indexed in Scilit:
- BreathlessNew England Journal of Medicine, 2012
- Pulmonary Tumor Thrombotic Microangiopathy Associated with Esophageal Squamous Cell CarcinomaInternal Medicine, 2011
- Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinomaPathology International, 2009
- Tumor AngiogenesisNew England Journal of Medicine, 2008
- Pulmonary Tumor Thrombotic MicroangiopathyJournal of Clinical Oncology, 2007
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2006
- Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factorPathology International, 2005
- Tumour microembolism presenting as "primary pulmonary hypertension"Thorax, 1997
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Pulmonary tumor thrombotic microangiopathy with pulmonary hypertensionCancer, 1990